BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1745977)

  • 1. Location, incidence, and malignant potential of duodenal gastrinomas.
    Thom AK; Norton JA; Axiotis CA; Jensen RT
    Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
    Thom AK; Norton JA; Doppman JL; Miller DL; Chang R; Jensen RT
    Surgery; 1992 Dec; 112(6):1002-8; discussion 1008-9. PubMed ID: 1455303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of patients with sporadic gastrinoma arising in the duodenum.
    Zogakis TG; Gibril F; Libutti SK; Norton JA; White DE; Jensen RT; Alexander HR
    Ann Surg; 2003 Jul; 238(1):42-8. PubMed ID: 12832964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal microgastrinomas associated with Zollinger-Ellison syndrome.
    Schröder W; Hölscher AH; Beckurts T; Richter TH; Höfler H; Siewert JR
    Hepatogastroenterology; 1996; 43(12):1465-9. PubMed ID: 8975949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.
    Norton JA; Doppman JL; Jensen RT
    Ann Surg; 1992 Jan; 215(1):8-18. PubMed ID: 1531004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.
    Thompson NW; Pasieka J; Fukuuchi A
    World J Surg; 1993; 17(4):455-62. PubMed ID: 8103249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal gastrinoma--clinical features and usefulness of selective arterial secretin injection test.
    Takasu A; Shimosegawa T; Fukudo S; Asakura T; Uchi M; Kimura K; Kashimura J; Satoh K; Koizumi M; Sasaki I; Hongo M; Suzuki T; Toyota T
    J Gastroenterol; 1998 Oct; 33(5):728-33. PubMed ID: 9773940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
    Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
    N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of surgical treatment for extrapancreatic gastrinomas.
    Chiarugi M; Pucciarelli M; Goletti O; Buccianti P; Cavina E
    Surg Gynecol Obstet; 1993 Aug; 177(2):153-7. PubMed ID: 8342095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.
    Sugg SL; Norton JA; Fraker DL; Metz DC; Pisegna JR; Fishbeyn V; Benya RV; Shawker TH; Doppman JL; Jensen RT
    Ann Surg; 1993 Aug; 218(2):138-44. PubMed ID: 8342993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy.
    Donow C; Pipeleers-Marichal M; Schröder S; Stamm B; Heitz PU; Klöppel G
    Cancer; 1991 Sep; 68(6):1329-34. PubMed ID: 1678681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
    Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
    World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome.
    Thompson NW; Vinik AI; Eckhauser FE
    Ann Surg; 1989 Apr; 209(4):396-404. PubMed ID: 2930285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the localization and surgical management of duodenal gastrinomas.
    Lawton GP; Modlin IM
    Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
    MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
    Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization, malignant potential, and surgical management of gastrinomas.
    Kisker O; Bastian D; Bartsch D; Nies C; Rothmund M
    World J Surg; 1998 Jul; 22(7):651-7; discussion 657-8. PubMed ID: 9606277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.